{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:07:34Z","timestamp":1794528454267,"version":"4.9.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1053230, Amendment No. 2 (NTD Modelling Consortium Supplement)"],"award-info":[{"award-number":["OPP1053230, Amendment No. 2 (NTD Modelling Consortium Supplement)"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1053230, Amendment No. 2 (NTD Modelling Consortium Supplement)"],"award-info":[{"award-number":["OPP1053230, Amendment No. 2 (NTD Modelling Consortium Supplement)"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1053230, Amendment No. 2 (NTD Modelling Consortium Supplement)"],"award-info":[{"award-number":["OPP1053230, Amendment No. 2 (NTD Modelling Consortium Supplement)"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1053230, Amendment No. 2 (NTD Modelling Consortium Supplement)"],"award-info":[{"award-number":["OPP1053230, Amendment No. 2 (NTD Modelling Consortium Supplement)"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13071-016-1768-y","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T11:56:36Z","timestamp":1473767796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators"],"prefix":"10.1186","volume":"9","author":[{"given":"Purushothaman","family":"Jambulingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaminathan","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J.","family":"de Vlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chellasamy","family":"Vinubala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. A.","family":"Stolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,13]]},"reference":[{"issue":"6","key":"1768_CR1","first-page":"491","volume":"75","author":"EA Ottesen","year":"1997","unstructured":"Ottesen EA, Duke BOL, Karam M, Behbehani K. Strategies and tools for the control\/elimination of lymphatic filariasis. Bull World Health Organ. 1997;75(6):491\u2013503.","journal-title":"Bull World Health Organ"},{"key":"1768_CR2","volume-title":"Elimination of lymphatic filariasis as a public health problem - resolution of the executive board of the WHO (WHA50.29)","author":"World Health Organization","year":"1997","unstructured":"World Health Organization. Elimination of lymphatic filariasis as a public health problem - resolution of the executive board of the WHO (WHA50.29). Geneva: Fiftieth World Health Assembly; 1997."},{"key":"1768_CR3","volume-title":"Global Programme to Eliminate Lymphatic filariasis: monitoring and epidemiological assessment of mass drug administration. A manual for national elimination programmes","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Global Programme to Eliminate Lymphatic filariasis: monitoring and epidemiological assessment of mass drug administration. A manual for national elimination programmes. Geneva: World Health Organization; 2011. Report No.: WHO\/HTM\/NTD\/PCT\/2011.4."},{"key":"1768_CR4","volume-title":"The regional strategic plan for elimination of lymphatic filariasis 2010\u20132015","author":"WHO Regional Office for South-East Asia","year":"2010","unstructured":"WHO Regional Office for South-East Asia. The regional strategic plan for elimination of lymphatic filariasis 2010\u20132015. New Delhia: World Health Organization, Regional Office for South-East Asia; 2010. Report No.: SEA-CD-203."},{"issue":"5","key":"1768_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.pt.2006.03.005","volume":"22","author":"E Michael","year":"2006","unstructured":"Michael E, Malecela-Lazaro MN, Kabali C, Snow LC, Kazura JW. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions. Trends Parasitol. 2006;22(5):226\u201333.","journal-title":"Trends Parasitol"},{"issue":"11","key":"1768_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.pt.2006.08.011","volume":"22","author":"E Michael","year":"2006","unstructured":"Michael E, Malecela-Lazaro MN, Maegga BT, Fischer P, Kazura JW. Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions. Trends Parasitol. 2006;22(11):529\u201335.","journal-title":"Trends Parasitol"},{"issue":"12","key":"1768_CR7","doi-asserted-by":"publisher","first-page":"e2584","DOI":"10.1371\/journal.pntd.0002584","volume":"7","author":"BK Chu","year":"2013","unstructured":"Chu BK, Deming M, Biritwum NK, Bougma WR, Dorkenoo AM, El-Setouhy M, et al. Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation. PLoS Negl Trop Dis. 2013;7(12):e2584.","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"1768_CR8","doi-asserted-by":"publisher","first-page":"e1926","DOI":"10.1371\/journal.pntd.0001926","volume":"6","author":"S Swaminathan","year":"2012","unstructured":"Swaminathan S, Perumal V, Adinarayanan S, Kaliannagounder K, Rengachari R, Purushothaman J. Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation. PLoS Negl Trop Dis. 2012;6(11):e1926.","journal-title":"PLoS Negl Trop Dis"},{"key":"1768_CR9","unstructured":"Directorate of National Vector Borne Disease Control Programme. Elimination of lymphatic filariasis, India: 2013\u20132014. National guidelines for transmission assessment survey (for district & state level health officials). Government of India, Delhi. 2014. http:\/\/nvbdcp.gov.in\/Doc\/TAS-National-Guidelines-2013-14.pdf . Accessed 27 Aug 2016."},{"key":"1768_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/bs.apar.2014.12.005","volume":"87","author":"WA Stolk","year":"2015","unstructured":"Stolk WA, Stone C, de Vlas SJ. Modelling lymphatic filariasis transmission and control: modelling frameworks, lessons learned and future directions. Adv Parasitol. 2015;87:249\u201391.","journal-title":"Adv Parasitol"},{"key":"1768_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1186\/s13071-015-1152-3","volume":"8","author":"MA Irvine","year":"2015","unstructured":"Irvine MA, Reimer LJ, Njenga SM, Gunawardena S, Kelly-Hope L, Bockarie M, et al. Modelling strategies to break transmission of lymphatic filariasis - aggregation, adherence and vector competence greatly alter elimination. Parasit Vectors. 2015;8:547.","journal-title":"Parasit Vectors"},{"issue":"1","key":"1768_CR12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/s13071-015-1132-7","volume":"8","author":"BK Singh","year":"2015","unstructured":"Singh BK, Michael E. Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, lymphatic filariasis. Parasit Vectors. 2015;8(1):522.","journal-title":"Parasit Vectors"},{"key":"1768_CR13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0038-1634505","volume":"37","author":"AP Plaisier","year":"1998","unstructured":"Plaisier AP, Subramanian S, Das PK, Souza W, Lapa T, Furtado AF, et al. The LYMFASIM simulation program for modeling lymphatic filariasis and its control. Methods Inf Med. 1998;37:97\u2013108.","journal-title":"Methods Inf Med"},{"issue":"Pt 5","key":"1768_CR14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1017\/S0031182004004822","volume":"128","author":"S Subramanian","year":"2004","unstructured":"Subramanian S, Stolk WA, Ramaiah KD, Plaisier AP, Krishnamoorthy K, Van Oortmarssen GJ, et al. The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India. Parasitology. 2004;128(Pt 5):467\u201382.","journal-title":"Parasitology"},{"issue":"9","key":"1768_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1086\/378354","volume":"188","author":"WA Stolk","year":"2003","unstructured":"Stolk WA, Subramanian S, Oortmarssen GJ, Das PK, Habbema JDF. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis. 2003;188(9):1371\u201381.","journal-title":"J Infect Dis"},{"issue":"13","key":"1768_CR16","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1017\/S0031182008000437","volume":"135","author":"WA Stolk","year":"2008","unstructured":"Stolk WA, de Vlas SJ, Borsboom GJ, Habbema JD. LYMFASIM, a simulation model for predicting the impact of lymphatic filariasis control: quantification for African villages. Parasitology. 2008;135(13):1583\u201398.","journal-title":"Parasitology"},{"issue":"1","key":"1768_CR17","doi-asserted-by":"publisher","first-page":"e1984","DOI":"10.1371\/journal.pntd.0001984","volume":"7","author":"WA Stolk","year":"2013","unstructured":"Stolk WA, ten Bosch QA, de Vlas SJ, Fischer PU, Weil GJ, Goldman AS. Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis. PLoS Negl Trop Dis. 2013;7(1):e1984.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1768_CR18","first-page":"2","volume":"1","author":"S Subramanian","year":"2008","unstructured":"Subramanian S, Pani SP, Ravi R, Krishnamoorthy K, Das PK. Mathematical models for lymphatic filariasis transmission and control: Challenges and prospects. Parasit Vectors. 2008;1(1):2.","journal-title":"Parasit Vectors"},{"issue":"5 Suppl","key":"1768_CR19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4269\/ajtmh.1996.55.165","volume":"55","author":"JDF Habbema","year":"1996","unstructured":"Habbema JDF, De Vlas SJ, Plaisier AP, Van Oortmarssen GJ. The microsimulation approach to epidemiologic modeling of helminthic infections, with special reference to schistosomiasis. Am J Trop Med Hyg. 1996;55(5 Suppl):165\u20139.","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"1768_CR20","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1111\/j.1365-3156.2006.01606.x","volume":"11","author":"MEA De Kraker","year":"2006","unstructured":"De Kraker MEA, Stolk WA, Van Oortmarssen GJ, Habbema JDF. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine\u2013albendazole or ivermectin\u2013albendazole combination therapy against Wuchereria bancrofti. Trop Med Int Health. 2006;11(5):718\u201328.","journal-title":"Trop Med Int Health"},{"issue":"9","key":"1768_CR21","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S0169-4758(99)01486-6","volume":"15","author":"EA Ottesen","year":"1999","unstructured":"Ottesen EA, Ismail MM, Horton J. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today. 1999;15(9):382\u20136.","journal-title":"Parasitol Today"},{"issue":"4","key":"1768_CR22","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0035-9203(03)00044-0","volume":"98","author":"NA Kshirsagar","year":"2004","unstructured":"Kshirsagar NA, Gogtay NJ, Garg BS, Deshmukh PR, Rajgor DD, Kadam VS, et al. Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India. Trans R Soc Trop Med Hyg. 2004;98(4):205\u201317.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"1768_CR23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4269\/ajtmh.2004.70.191","volume":"70","author":"M El Setouhy","year":"2004","unstructured":"El Setouhy M, Ramzy RMR, Ahmed ES, Kandil AM, Hussain O, Farid HA, et al. A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis. Am J Trop Med Hyg. 2004;70(2):191\u20136.","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"1768_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0169-4758(00)01691-4","volume":"16","author":"AP Plaisier","year":"2000","unstructured":"Plaisier AP, Stolk WA, van Oortmarssen GJ, Habbema JD. Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection. Parasitol Today. 2000;16(7):298\u2013302.","journal-title":"Parasitol Today"},{"issue":"3","key":"1768_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1179\/136485905X29666","volume":"99","author":"P Vanamail","year":"2005","unstructured":"Vanamail P, Ramaiah KD, Subramanian S, Pani SP, Yuvaraj J, Das PK. Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India. Ann Trop Med Parasitol. 2005;99(3):237\u201342.","journal-title":"Ann Trop Med Parasitol"},{"issue":"10","key":"1768_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0169-4758(97)01130-7","volume":"13","author":"GJ Weil","year":"1997","unstructured":"Weil GJ, Lammie PJ, Weiss N. The ICT filariasis test: a rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today. 1997;13(10):401\u20134.","journal-title":"Parasitol Today"},{"key":"1768_CR27","doi-asserted-by":"crossref","unstructured":"Weil GJ, Ramzy RM. Diagnostic tools for filariasis elimination programs. Trends Parasitol. 2007;23:78-82.","DOI":"10.1016\/j.pt.2006.12.001"},{"issue":"1","key":"1768_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/infdis\/170.1.247","volume":"170","author":"S Chanteau","year":"1994","unstructured":"Chanteau S, Moulia-Pelat JP, Glaziou P, Nguyen NL, Luquiaud P, Plichart C, et al. Og4C3 circulating antigen: a marker of infection and adult worm burden in Wuchereria bancrofti filariasis. J Infect Dis. 1994;170(1):247\u201350.","journal-title":"J Infect Dis"},{"issue":"2","key":"1768_CR29","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1093\/infdis\/156.2.350","volume":"156","author":"GJ Weil","year":"1987","unstructured":"Weil GJ, Jain DC, Santhanam S, Malhotra A, Kumar H, Sethumadhavan KV, et al. A monoclonal antibody-based enzyme immunoassay for detecting parasite antigenemia in bancroftian filariasis. J Infect Dis. 1987;156(2):350\u20135.","journal-title":"J Infect Dis"},{"issue":"10","key":"1768_CR30","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0169-4758(97)01125-3","volume":"13","author":"L Nicolas","year":"1997","unstructured":"Nicolas L. New tools for diagnosis and monitoring of bancroftian filariasis parasitism: the Polynesian experience. Parasitol Today. 1997;13(10):170\u2013375.","journal-title":"Parasitol Today"},{"issue":"3","key":"1768_CR31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4269\/ajtmh.1996.55.333","volume":"55","author":"GJ Weil","year":"1996","unstructured":"Weil GJ, Ramzy RM, Chandrashekar R, Gad AM, Lowrie Jr RC, Faris R. Parasite antigenemia without microfilaremia in bancroftian filariasis. Am J Trop Med Hyg. 1996;55(3):333\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"1768_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0035-9203(01)90094-X","volume":"95","author":"IP Sunish","year":"2001","unstructured":"Sunish IP, Rajendran R, Satyanarayana K, Munirathinam A, Gajanana A. Immunochromatographic test (ICT) for estimation of true prevalence of bancroftian filariasis in an endemic area in southern India. Trans R Soc Trop Med Hyg. 2001;95(6):607\u20139.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"1768_CR33","first-page":"304","volume":"17","author":"SP Pani","year":"2004","unstructured":"Pani SP, Hoti SL, Vanamail P, Das LK. Comparison of an immunochromatographic card test with night blood smear examination for detection of Wuchereria bancrofti microfilaria carriers. Natl Med J India. 2004;17(6):304\u20136.","journal-title":"Natl Med J India"},{"issue":"6","key":"1768_CR34","first-page":"771","volume":"121","author":"D Das","year":"2005","unstructured":"Das D, Kumar S, Sahoo PK, Dash AP. A survey of bancroftian filariasis for microfilariae & circulating antigenaemia in two villages of Madhya Pradesh. Indian J Med Res. 2005;121(6):771\u20135.","journal-title":"Indian J Med Res"},{"issue":"1","key":"1768_CR35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4269\/ajtmh.2008.78.28","volume":"78","author":"G Dreyer","year":"2008","unstructured":"Dreyer G, Lins R, Noroes J, Rizzo JA, Figueredo-Silva J. Sensitivity of the Immunochromatographic card test relative to detection of adult Wuchereria bancrofti worms by ultrasound. Am J Trop Med Hyg. 2008;78(1):28\u201334.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"1768_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1051\/parasite\/1999064355","volume":"6","author":"NL Nguyen","year":"1999","unstructured":"Nguyen NL, Plichart C, Esterre P. Assessment of immunochromatographic test for rapid lymphatic filariasis diagnosis. Parasite. 1999;6(4):355\u20138.","journal-title":"Parasite"},{"issue":"1","key":"1768_CR37","doi-asserted-by":"publisher","first-page":"e1479","DOI":"10.1371\/journal.pntd.0001479","volume":"6","author":"K Gass","year":"2012","unstructured":"Gass K, de Beau Rochars MV, Boakye D, Bradley M, Fischer PU, Gyapong J, et al. A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis. PLoS Negl Trop Dis. 2012;6(1):e1479.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1768_CR38","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1186\/s12879-015-1317-x","volume":"15","author":"R Gounoue-Kamkumo","year":"2015","unstructured":"Gounoue-Kamkumo R, Nana-Djeunga HC, Bopda J, Akame J, Tarini A, Kamgno J. Loss of sensitivity of immunochromatographic test (ICT) for lymphatic filariasis diagnosis in low prevalence settings: consequence in the monitoring and evaluation procedures. BMC Infect Dis. 2015;15(1):579.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"1768_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4269\/ajtmh.13-0089","volume":"89","author":"GJ Weil","year":"2013","unstructured":"Weil GJ, Curtis KC, Fakoli L, Fischer K, Gankpala L, Lammie PJ, et al. Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood. Am J Trop Med Hyg. 2013;89(1):11\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"1768_CR40","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s13071-015-0979-y","volume":"8","author":"TC Yahathugoda","year":"2015","unstructured":"Yahathugoda TC, Supali T, Rao RU, Djuardi Y, Stefani D, Pical F, et al. A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration. Parasit Vectors. 2015;8:369.","journal-title":"Parasit Vectors"},{"issue":"9","key":"1768_CR41","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.4049\/jimmunol.138.9.3035","volume":"138","author":"GJ Weil","year":"1987","unstructured":"Weil GJ, Liftis F. Identification and partial characterization of a parasite antigen in sera from humans infected with Wuchereria bancrofti. J Immunol. 1987;138(9):3035\u201341.","journal-title":"J Immunol"},{"key":"1768_CR42","unstructured":"Centers for Disease Control and Prevention (CDC). DPDx - Laboratory identification of parasitic diseases of public health concern. Lymphatic filariasis. Atlanta: Centers for Disease Control and Prevention; http:\/\/www.cdc.gov\/dpdx\/lymphaticFilariasis\/ . Accessed 27 Aug 2016."},{"issue":"9477","key":"1768_CR43","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/S0140-6736(05)66714-1","volume":"365","author":"WA Stolk","year":"2005","unstructured":"Stolk WA, De Vlas SJ, Habbema JDF. Anti-Wolbachia treatment for lymphatic filariasis. Lancet. 2005;365(9477):2067\u20138.","journal-title":"Lancet"},{"key":"1768_CR44","unstructured":"NTD Modelling Consortium. http:\/\/www.ntdmodelling.org\/ . Accessed 27 Aug 2016."},{"issue":"1","key":"1768_CR45","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1186\/s13071-015-1235-1","volume":"8","author":"TD Hollingsworth","year":"2015","unstructured":"Hollingsworth TD, Adams ER, Anderson RM, Atkins K, Bartsch S, Basanez MG, et al. Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases. Parasit Vectors. 2015;8(1):630.","journal-title":"Parasit Vectors"},{"issue":"2","key":"1768_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pt.2004.11.011","volume":"21","author":"HP Duerr","year":"2005","unstructured":"Duerr HP, Dietz K, Eichner M. Determinants of the eradicability of filarial infections: a conceptual approach. Trends Parasitol. 2005;21(2):88\u201396.","journal-title":"Trends Parasitol"},{"key":"1768_CR47","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s13071-014-0466-x","volume":"7","author":"J Cano","year":"2014","unstructured":"Cano J, Rebollo MP, Golding N, Pullan RL, Crellen T, Soler A, et al. The global distribution and transmission limits of lymphatic filariasis: past and present. Parasit Vectors. 2014;7:466.","journal-title":"Parasit Vectors"},{"issue":"Pt 6","key":"1768_CR48","first-page":"601","volume":"121","author":"K Polman","year":"2000","unstructured":"Polman K, de Vlas SJ, Gryseels B, Deelder AM. Relating serum circulating anodic antigens to faecal egg counts in Schistosoma mansoni infections: a modelling approach. Parasitology. 2000;121(Pt 6):601\u201310.","journal-title":"Parasitology"},{"issue":"4","key":"1768_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1473-3099(04)00973-9","volume":"4","author":"E Michael","year":"2004","unstructured":"Michael E, Malecela-Lazaro MN, Simonsen PE, Pedersen EM, Barker G, Kumar A, et al. Mathematical modelling and the control of lymphatic filariasis. Lancet Infect Dis. 2004;4(4):223\u201334.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"1768_CR50","doi-asserted-by":"publisher","first-page":"e2874","DOI":"10.1371\/journal.pone.0002874","volume":"3","author":"M Gambhir","year":"2008","unstructured":"Gambhir M, Michael E. Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis. PLoS One. 2008;3(8):e2874.","journal-title":"PLoS One"},{"key":"1768_CR51","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1741-7007-8-22","volume":"8","author":"M Gambhir","year":"2010","unstructured":"Gambhir M, Bockarie M, Tisch D, Kazura J, Remais J, Spear R, et al. Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis. BMC Biol. 2010;8:22.","journal-title":"BMC Biol"},{"key":"1768_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12916-016-0557-y","volume":"14","author":"E Michael","year":"2016","unstructured":"Michael E, Singh BK. Heterogeneous dynamics, robustness\/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis. BMC Med. 2016;14:14.","journal-title":"BMC Med"},{"issue":"5","key":"1768_CR53","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ijpara.2010.12.009","volume":"41","author":"HP Duerr","year":"2011","unstructured":"Duerr HP, Raddatz G, Eichner M. Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination. Int J Parasitol. 2011;41(5):581\u20139.","journal-title":"Int J Parasitol"},{"issue":"4","key":"1768_CR54","doi-asserted-by":"publisher","first-page":"e1548","DOI":"10.1371\/journal.pntd.0001548","volume":"6","author":"MG Bas\u00e1\u00f1ez","year":"2012","unstructured":"Bas\u00e1\u00f1ez MG, McCarthy JS, French MD, Yang GJ, Walker M, Gambhir M, et al. A research agenda for helminth diseases of humans: modelling for control and elimination. PLoS Negl Trop Dis. 2012;6(4):e1548.","journal-title":"PLoS Negl Trop Dis"},{"key":"1768_CR55","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1017\/S0031182097002254","volume":"116","author":"S Subramanian","year":"1998","unstructured":"Subramanian S, Krishnamoorthy K, Ramaiah KD, Habbema JDF, Das PK, Plaisier AP. The relationship between microfilarial load in the human host and uptake and development of Wuchereria bancrofti microfilariae by Culex quinquefasciatus: a study under natural conditions. Parasitology. 1998;116:243\u201355.","journal-title":"Parasitology"},{"issue":"Suppl 2","key":"1768_CR56","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1179\/000349802125002509","volume":"96","author":"G Pichon","year":"2002","unstructured":"Pichon G. Limitation and facilitation in the vectors and other aspects of the dynamics of filarial transmission: the need for vector control against Anopheles-transmitted filariasis. Ann Trop Med Parasitol. 2002;96 Suppl 2:S143\u2013S52.","journal-title":"Ann Trop Med Parasitol"},{"issue":"1","key":"1768_CR57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.0269-283X.2004.0470.x","volume":"18","author":"WA Stolk","year":"2004","unstructured":"Stolk WA, Van Oortmarssen GJ, Subramanian S, Das PK, Borsboom GJJM, Habbema JDF, et al. Assessing density dependence in the transmission of lymphatic filariasis: uptake and development of Wuchereria bancrofti microfilariae in the vector mosquitoes. Med Vet Entomol. 2004;18(1):57\u201360.","journal-title":"Med Vet Entomol"},{"issue":"3","key":"1768_CR58","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/j.1365-2915.2006.00629.x","volume":"20","author":"LC Snow","year":"2006","unstructured":"Snow LC, Bockarie MJ, Michael E. Transmission dynamics of lymphatic filariasis: vector-specific density dependence in the development of Wuchereria bancrofti infective larvae in mosquitoes. Med Vet Entomol. 2006;20(3):261\u201372.","journal-title":"Med Vet Entomol"},{"issue":"7","key":"1768_CR59","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1046\/j.1365-3024.2001.00398.x","volume":"23","author":"E Michael","year":"2001","unstructured":"Michael E, Simonsen PE, Malecela M, Jaoko WG, Pedersen EM, Mukoko D, et al. Transmission intensity and the immunoepidemiology of bancroftian filariasis in East Africa. Parasite Immunol. 2001;23(7):373\u201388.","journal-title":"Parasite Immunol"},{"issue":"Pt 5","key":"1768_CR60","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1017\/S0031182004005980","volume":"129","author":"WA Stolk","year":"2004","unstructured":"Stolk WA, Ramaiah KD, Van Oortmarssen GJ, Das PK, Habbema JDF, De Vlas SJ. Meta-analysis of age-prevalence patterns in lymphatic filariasis: no decline in microfilaraemia prevalence in older age groups as predicted by models with acquired immunity. Parasitology. 2004;129(Pt 5):605\u201312.","journal-title":"Parasitology"},{"issue":"6","key":"1768_CR61","doi-asserted-by":"publisher","first-page":"e67004","DOI":"10.1371\/journal.pone.0067004","volume":"8","author":"BK Singh","year":"2013","unstructured":"Singh BK, Bockarie MJ, Gambhir M, Siba PM, Tisch DJ, Kazura J, et al. Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea. PLoS One. 2013;8(6):e67004.","journal-title":"PLoS One"},{"issue":"1","key":"1768_CR62","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0035-9203(00)90431-0","volume":"94","author":"SW Lindsay","year":"2000","unstructured":"Lindsay SW, Thomas CJ. Mapping and estimating the population at risk from lymphatic filariasis in Africa [In Process Citation]. Trans R Soc Trop Med Hyg. 2000;94(1):37\u201345.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1768_CR63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1475-2883-5-12","volume":"5","author":"S Sabesan","year":"2006","unstructured":"Sabesan S, Raju HK, Srividya A, Das PK. Delimitation of lymphatic filariasis transmission risk areas: a geo-environmental approach. Filaria J. 2006;5:12.","journal-title":"Filaria J"},{"issue":"2","key":"1768_CR64","doi-asserted-by":"publisher","first-page":"e32202","DOI":"10.1371\/journal.pone.0032202","volume":"7","author":"H Slater","year":"2012","unstructured":"Slater H, Michael E. Predicting the current and future potential distributions of lymphatic filariasis in Africa using maximum entropy ecological niche modelling. PLoS One. 2012;7(2):e32202.","journal-title":"PLoS One"},{"issue":"1","key":"1768_CR65","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4081\/gh.2013.63","volume":"8","author":"MC Stanton","year":"2013","unstructured":"Stanton MC, Molyneux DH, Kyelem D, Bougma RW, Koudou BG, Kelly-Hope LA. Baseline drivers of lymphatic filariasis in Burkina Faso. Geospat Health. 2013;8(1):159\u201373.","journal-title":"Geospat Health"},{"issue":"9","key":"1768_CR66","doi-asserted-by":"publisher","first-page":"e2416","DOI":"10.1371\/journal.pntd.0002416","volume":"7","author":"PN Okorie","year":"2013","unstructured":"Okorie PN, Ademowo GO, Saka Y, Davies E, Okoronkwo C, Bockarie MJ, et al. Lymphatic filariasis in Nigeria; micro-stratification overlap mapping (MOM) as a prerequisite for cost-effective resource utilization in control and surveillance. PLoS Negl Trop Dis. 2013;7(9):e2416.","journal-title":"PLoS Negl Trop Dis"},{"key":"1768_CR67","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2883-4-6","volume":"4","author":"FO Richards Jr","year":"2005","unstructured":"Richards Jr FO, Eigege A, Pam D, Kal A, Lenhart A, Oneyka JO, et al. Mass ivermectin treatment for onchocerciasis: lack of evidence for collateral impact on transmission of Wuchereria bancrofti in areas of co-endemicity. Filaria J. 2005;4:6.","journal-title":"Filaria J"},{"issue":"6","key":"1768_CR68","doi-asserted-by":"publisher","first-page":"e2273","DOI":"10.1371\/journal.pntd.0002273","volume":"7","author":"JB Koroma","year":"2013","unstructured":"Koroma JB, Sesay S, Sonnie M, Hodges MH, Sahr F, Zhang Y, et al. Impact of three rounds of mass drug administration on lymphatic filariasis in areas previously treated for onchocerciasis in Sierra Leone. PLoS Negl Trop Dis. 2013;7(6):e2273.","journal-title":"PLoS Negl Trop Dis"},{"key":"1768_CR69","volume-title":"Community directed treatment with ivermectin: report of a multi-country study","author":"World Health Organization","year":"1996","unstructured":"World Health Organization. Community directed treatment with ivermectin: report of a multi-country study. Geneva: UNDP\/World Bank\/WHO Special Programme for Research and Training in Tropical Diseases (TDR), in collaboration with Onchocerciasis Control Programme in West Africa (OCP) and the African Programme for Onchocerciasis Control (APOC); 1996. Report No.: TDR\/AFR\/RP\/96.1."},{"issue":"10","key":"1768_CR70","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.socscimed.2007.01.018","volume":"64","author":"U Amazigo","year":"2007","unstructured":"Amazigo U, Okeibunor J, Matovu V, Zoure H, Bump J, Seketeli A. Performance of predictors: evaluating sustainability in community-directed treatment projects of the African programme for onchocerciasis control. Soc Sci Med. 2007;64(10):2070\u201382.","journal-title":"Soc Sci Med"},{"issue":"1","key":"1768_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1046\/j.1365-3156.2002.00826.x","volume":"7","author":"WR Brieger","year":"2002","unstructured":"Brieger WR, Otusanya SA, Oke GA, Oshiname FO, Adeniyi JD. Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria. Trop Med Int Health. 2002;7(1):11\u20138.","journal-title":"Trop Med Int Health"},{"issue":"11","key":"1768_CR72","doi-asserted-by":"publisher","first-page":"e2447","DOI":"10.1371\/journal.pntd.0002447","volume":"7","author":"A Krentel","year":"2013","unstructured":"Krentel A, Fischer PU, Weil GJ. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. PLoS Negl Trop Dis. 2013;7(11):e2447.","journal-title":"PLoS Negl Trop Dis"},{"key":"1768_CR73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2049-9957-3-31","volume":"3","author":"MA Hussain","year":"2014","unstructured":"Hussain MA, Sitha AK, Swain S, Kadam S, Pati S. Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance. Infect Dis Poverty. 2014;3:31.","journal-title":"Infect Dis Poverty"},{"key":"1768_CR74","doi-asserted-by":"crossref","unstructured":"Kisoka WJ, Tersbol BP, Meyrowitsch DW, Simonsen PE, Mushi DL. Community Members\u2019 Perceptions of Mass Drug Administration for Control of Lymphatic Filariasis in Rural and Urban Tanzania. J Biosoc Sci. 2016;48:94-112.","DOI":"10.1017\/S0021932015000024"},{"issue":"1","key":"1768_CR75","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/00034980020035942","volume":"95","author":"M Gyapong","year":"2001","unstructured":"Gyapong M, Gyapong JO, Owusu-Banahene G. Community-directed treatment: the way forward to eliminating lymphatic filariasis as a public-health problem in Ghana. Ann Trop Med Parasitol. 2001;95(1):77\u201386.","journal-title":"Ann Trop Med Parasitol"},{"issue":"Suppl 1","key":"1768_CR76","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1080\/00034989859627","volume":"92","author":"AD Hopkins","year":"1998","unstructured":"Hopkins AD. Mectizan delivery systems and cost recovery in the Central African Republic. Ann Trop Med Parasitol. 1998;92 Suppl 1:S97\u2013100.","journal-title":"Ann Trop Med Parasitol"},{"issue":"1","key":"1768_CR77","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/2229-5070.113917","volume":"3","author":"S Ghosh","year":"2013","unstructured":"Ghosh S, Samanta A, Kole S. Mass drug administration for elimination of lymphatic filariasis: Recent experiences from a district of West Bengal, India. Trop Parasitol. 2013;3(1):67\u201371.","journal-title":"Trop Parasitol"},{"key":"1768_CR78","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1756-3305-3-70","volume":"3","author":"N Bhullar","year":"2010","unstructured":"Bhullar N, Maikere J. Challenges in mass drug administration for treating lymphatic filariasis in Papua, Indonesia. Parasit Vectors. 2010;3:70.","journal-title":"Parasit Vectors"},{"key":"1768_CR79","unstructured":"Global programme to eliminate lymphatic filariasis: progress report, 2014. Wkly Epidemiol Rec. 2015;90(38):489\u2013504."},{"issue":"1","key":"1768_CR80","doi-asserted-by":"crossref","first-page":"e000021","DOI":"10.1136\/bmjgh-2015-000021","volume":"1","author":"CM Stone","year":"2016","unstructured":"Stone CM, Kastner R, Steinmann P, Chitnis N, Tanner M, Tediosi F. Modelling the health impact and cost-effectiveness of lymphatic filariasis eradication under varying levels of mass drug administration scale-up and geographic coverage. BMJ Global Health. 2016;1(1):e000021.","journal-title":"BMJ Global Health"},{"key":"1768_CR81","unstructured":"Guidelines on elimination of lymphatic filariasis, India. Delhi: Directorate of National Vector Borne Disease Control Programme, Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India. 2009."},{"issue":"9","key":"1768_CR82","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1089\/vbz.2012.1238","volume":"13","author":"S Sabesan","year":"2013","unstructured":"Sabesan S, Raju KH, Subramanian S, Srivastava PK, Jambulingam P. Lymphatic filariasis transmission risk map of India, based on a geo-environmental risk model. Vector Borne Zoonotic Dis. 2013;13(9):657\u201365.","journal-title":"Vector Borne Zoonotic Dis"},{"issue":"9","key":"1768_CR83","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/trstmh\/tru057","volume":"108","author":"BV Babu","year":"2014","unstructured":"Babu BV, Babu GR. Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review. Trans R Soc Trop Med Hyg. 2014;108(9):538\u201349.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1768_CR84","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.actatropica.2014.02.004","volume":"133","author":"AN Shriram","year":"2014","unstructured":"Shriram AN, Krishnamoorthy K, Sivan A, Saha BP, Kumaraswami V, Vijayachari P. Impact of MDA and the prospects of elimination of the lone focus of diurnally sub periodic lymphatic filariasis in Nicobar Islands, India. Acta Trop. 2014;133:93\u20137.","journal-title":"Acta Trop"},{"issue":"3","key":"1768_CR85","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/tropej\/fmt101","volume":"60","author":"IP Sunish","year":"2014","unstructured":"Sunish IP, Munirathinam A, Kalimuthu M, Ashok Kumar V, Tyagi BK. Persistence of lymphatic filarial infection in the paediatric population of rural community, after six rounds of annual mass drug administrations. J Trop Pediatr. 2014;60(3):245\u20138.","journal-title":"J Trop Pediatr"},{"issue":"1","key":"1768_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parint.2014.08.005","volume":"64","author":"IP Sunish","year":"2015","unstructured":"Sunish IP, Kalimuthu M, Rajendran R, Munirathinam A, Ashok Kumar V, Nagaraj J, et al. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10 year period in India. Parasitol Int. 2015;64(1):1\u20134.","journal-title":"Parasitol Int"},{"issue":"5","key":"1768_CR87","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4269\/ajtmh.2005.73.881","volume":"73","author":"WA Stolk","year":"2005","unstructured":"Stolk WA, van Oortmarssen GJ, Pani SP, de Vlas SJ, Subramanian S, Das PK, et al. Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis. Am J Trop Med Hyg. 2005;73(5):881\u20137.","journal-title":"Am J Trop Med Hyg"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-016-1768-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-016-1768-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-016-1768-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T02:36:29Z","timestamp":1692498989000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-016-1768-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,13]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1768"],"URL":"https:\/\/doi.org\/10.1186\/s13071-016-1768-y","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,13]]},"assertion":[{"value":"23 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"501"}}